TerrAscend (TSNDF) Stock Price, News & Analysis

Company Overview

TerrAscend Corp. is a North American cannabis company that cultivates, manufactures and sells cannabis products through a portfolio of brands and retail operations. Its products include cannabis flower, pre-rolls, vaporizer products, concentrates, edibles, tinctures and other related goods, depending on the market.

The company operates in several U.S. cannabis markets, including Pennsylvania, New Jersey, Maryland, Michigan and California. Its retail portfolio has included dispensaries operating under names such as The Apothecarium, Gage and Cookies, while its product brands have included Kind Tree, Legend and Gage. TerrAscend’s operations are generally vertically integrated, combining cultivation and manufacturing with wholesale distribution and direct-to-consumer retail sales.

TerrAscend was established in 2017 and has expanded through acquisitions, licensing arrangements and the development of its own cultivation, processing and retail infrastructure. The company serves both medical and adult-use cannabis consumers in jurisdictions where those activities are permitted, with its geographic presence and product availability varying according to local regulations.

Key Stats

• Today's Range: $0.66 to $0.70
• 50-Day Range: $0.47 to $0.69
• 52-Week Range: $0.35 to $1.45
• Volume: 196,457 shs
• Average Volume: 310,303 shs
• Market Capitalization: $203.44 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Buy

TerrAscend Stock Analysis - MarketRank™

TerrAscend scored higher than 40% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.5 / 5
• Analyst Rating: Buy

Consensus Rating

TerrAscend has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

TerrAscend has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for TerrAscend are expected to grow in the coming year, from ($0.07) to ($0.03) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of TerrAscend is -6.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of TerrAscend is -6.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

TerrAscend has a P/B Ratio of 2.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.50% of the float of TerrAscend has been sold short.

Short Interest Ratio / Days to Cover

TerrAscend has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in TerrAscend has recently decreased by 21.89%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

TerrAscend does not currently pay a dividend.

Dividend Growth

TerrAscend does not have a long track record of dividend growth.

News and Social Media

• Score: 4.3 / 5
• News Sentiment: N/A

News Sentiment

TerrAscend has a news sentiment score of 0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for TerrAscend this week, compared to 0 articles on an average week.

Search Interest

1 people have searched for TSNDF on MarketBeat in the last 30 days.

MarketBeat Follows

2 people have added TerrAscend to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, TerrAscend insiders have not sold or bought any company stock.

Percentage Held by Insiders

31.86% of the stock of TerrAscend is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

5.83% of the stock of TerrAscend is held by institutions.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 9/21/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:TSNDF
• Previous Symbol: OTC:TSNDF
• CIK: 1778129
• Web: www.terrascend.com
• Phone: 855-837-7295
• Fax: N/A
• Employees: 1,038
• Year Founded: 2017

Profitability

• EPS (Trailing Twelve Months): ($0.11)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$81.33 million
• Net Margins: -31.01%
• Pretax Margin: 1.50%
• Return on Equity: -32.93%
• Return on Assets: -5.49%

Debt

• Debt-to-Equity Ratio: 2.37
• Current Ratio: 1.83
• Quick Ratio: 1.20

Sales & Book Value

• Annual Sales: $260.56 million
• Price / Sales: 0.79
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.32 per share
• Price / Book: 2.09

Miscellaneous

• Outstanding Shares: 309,176,000
• Free Float: 210,673,000
• Market Cap: $206.93 million
• Optionable: Not Optionable
• Beta: 1.44